Newron Pharmaceuticals
NWRN.SW
#8222
Rank
NZ$0.35 B
Marketcap
$18.55
Share price
4.97%
Change (1 day)
20.86%
Change (1 year)

EPS for Newron Pharmaceuticals (NWRN.SW)

EPS in 2023: -$1.92

According to Newron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.92. In 2023 the company made an earnings per share (EPS) of -$1.92 a decrease over its 2022 EPS that were of -$1.88.

EPS history for Newron Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023-$1.922.03%
2022-$1.8815.39%
2021-$1.63-31.32%
2020-$2.3714.74%
2019-$2.0736.6%
2018-$1.51159.87%
2017-$0.58-67.81%
2016-$1.81-39.24%
2015-$2.98107.61%
2014-$1.4315.8%
2013-$1.24119.91%
2012-$0.56-66.51%
2011-$1.68-71.49%
2010-$5.90-10.83%
2009-$6.6142.06%
2008-$4.6556.53%
2007-$2.97-52.84%
2006-$6.30-188.53%
2005$7.12